Medspas are leading the charge in offering GLP-1 treatments, with 60% of medspas in the U.S. now providing these services, compared to 35% of aesthetic physician offices. Average spend per patient ...
The drugs initially were approved as a treatment for type 2 diabetes because they help lower blood sugar levels. But subsequent studies found that GLP-1 drugs also help people loseweight.